Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-003590

Chief Executive Officer sold 2,707 shares at $6.15 ($16,654)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2021-01-12 Sale −2,707 $6.15 $16,654 3,695 D
Open-market sales · 2,707 sh · avg $6.15 · $16,654
Loading xslF345X03/tm212950-1_4seq1.xml…